Do analysts recommend ZCMD or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, ZCMD or RDGT?

Ridgetech has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.09 -$6.31M N/A N/A Ridgetech $132.16M 0.03 -$1.25M N/A N/A

Is ZCMD or RDGT more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A Ridgetech N/A N/A N/A

Does the media refer more to ZCMD or RDGT?

In the previous week, Zhongchao had 1 more articles in the media than Ridgetech. MarketBeat recorded 2 mentions for Zhongchao and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 0.79 beat Zhongchao's score of -0.28 indicating that Ridgetech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zhongchao 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer IVF or ZCMD?

INVO Fertility currently has a consensus target price of $20.00, indicating a potential upside of 2,611.86%. Given INVO Fertility's stronger consensus rating and higher possible upside, equities analysts clearly believe INVO Fertility is more favorable than Zhongchao. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, IVF or ZCMD?

Zhongchao has higher revenue and earnings than INVO Fertility. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio INVO Fertility $6.84M 0.27 -$25.13M -$33.83 N/A Zhongchao $11.38M 0.09 -$6.31M N/A N/A

Do analysts prefer HKPD or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, HKPD or ZCMD?

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.13 -$1.14M N/A N/A Zhongchao $11.38M 0.09 -$6.31M N/A N/A

Is HKPD or ZCMD more profitable?

Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Zhongchao N/A N/A N/A

Do analysts recommend MNDR or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mobile-health Network Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, MNDR or ZCMD?

Mobile-health Network Solutions has higher earnings, but lower revenue than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mobile-health Network Solutions $7.65M 0.17 -$3.38M N/A N/A Zhongchao $11.38M 0.09 -$6.31M N/A N/A

Is MNDR or ZCMD more profitable?

Company Net Margins Return on Equity Return on Assets Mobile-health Network Solutions N/A N/A N/A Zhongchao N/A N/A N/A

Do analysts rate NIVF or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, NIVF or ZCMD?

NewGenIvf Group has higher earnings, but lower revenue than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NewGenIvf Group $4.73M 0.05 $9.88M N/A N/A Zhongchao $11.38M 0.09 -$6.31M N/A N/A

Is NIVF or ZCMD more profitable?

Company Net Margins Return on Equity Return on Assets NewGenIvf Group N/A N/A N/A Zhongchao N/A N/A N/A

Zhongchao (ZCMD) Competitors

$1.57 -0.14 (-8.19%)

As of 01:17 PM Eastern

Compare

ZCMD vs. RDGT, IVF, HKPD, MNDR, and NIVF

Should you buy Zhongchao stock or one of its competitors? Zhongchao's main competitors and comparable companies include Ridgetech (RDGT), INVO Fertility (IVF), Hong Kong Pharma Digital Technology (HKPD), Mobile-health Network Solutions (MNDR), and NewGenIvf Group (NIVF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Zhongchao compare to Ridgetech?

Zhongchao (NASDAQ:ZCMD) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Zhongchao has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market.

In the previous week, Zhongchao had 1 more articles in the media than Ridgetech. MarketBeat recorded 2 mentions for Zhongchao and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 0.79 beat Zhongchao's score of -0.28 indicating that Ridgetech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zhongchao	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Ridgetech	N/A	N/A	N/A

Ridgetech has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.09	-$6.31M	N/A	N/A
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.7% of Zhongchao shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Comparatively, 22.6% of Ridgetech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Zhongchao and Ridgetech tied by winning 4 of the 8 factors compared between the two stocks.

How does Zhongchao compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

INVO Fertility currently has a consensus target price of $20.00, indicating a potential upside of 2,611.86%. Given INVO Fertility's stronger consensus rating and higher possible upside, equities analysts clearly believe INVO Fertility is more favorable than Zhongchao.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Zhongchao had 2 more articles in the media than INVO Fertility. MarketBeat recorded 2 mentions for Zhongchao and 0 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 0.00 beat Zhongchao's score of -0.28 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Overall Sentiment
INVO Fertility	Neutral
Zhongchao	Neutral

Zhongchao has higher revenue and earnings than INVO Fertility.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84M	0.27	-$25.13M	-$33.83	N/A
Zhongchao	$11.38M	0.09	-$6.31M	N/A	N/A

Zhongchao has a net margin of 0.00% compared to INVO Fertility's net margin of -116.29%. Zhongchao's return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-116.29%	-85.54%	-31.05%
Zhongchao	N/A	N/A	N/A

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 1.7% of Zhongchao shares are held by institutional investors. 0.4% of INVO Fertility shares are held by insiders. Comparatively, 28.6% of Zhongchao shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

INVO Fertility has a beta of 2.39, suggesting that its stock price is 139% more volatile than the broader market. Comparatively, Zhongchao has a beta of -0.03, suggesting that its stock price is 103% less volatile than the broader market.

Summary

INVO Fertility and Zhongchao tied by winning 7 of the 14 factors compared between the two stocks.

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Zhongchao	N/A	N/A	N/A

1.7% of Zhongchao shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.13	-$1.14M	N/A	N/A
Zhongchao	$11.38M	0.09	-$6.31M	N/A	N/A

Hong Kong Pharma Digital Technology has a beta of 2.57, meaning that its stock price is 157% more volatile than the broader market. Comparatively, Zhongchao has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Zhongchao had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Zhongchao and 0 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 beat Zhongchao's score of -0.28 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
Zhongchao	Neutral

Summary

Hong Kong Pharma Digital Technology beats Zhongchao on 5 of the 8 factors compared between the two stocks.

How does Zhongchao compare to Mobile-health Network Solutions?

Mobile-health Network Solutions (NASDAQ:MNDR) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

1.7% of Zhongchao shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Zhongchao had 2 more articles in the media than Mobile-health Network Solutions. MarketBeat recorded 2 mentions for Zhongchao and 0 mentions for Mobile-health Network Solutions. Mobile-health Network Solutions' average media sentiment score of 0.00 beat Zhongchao's score of -0.28 indicating that Mobile-health Network Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Mobile-health Network Solutions	Neutral
Zhongchao	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Mobile-health Network Solutions	N/A	N/A	N/A
Zhongchao	N/A	N/A	N/A

Mobile-health Network Solutions has higher earnings, but lower revenue than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobile-health Network Solutions	$7.65M	0.17	-$3.38M	N/A	N/A
Zhongchao	$11.38M	0.09	-$6.31M	N/A	N/A

Mobile-health Network Solutions has a beta of -0.82, suggesting that its stock price is 182% less volatile than the broader market. Comparatively, Zhongchao has a beta of -0.03, suggesting that its stock price is 103% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobile-health Network Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Zhongchao beats Mobile-health Network Solutions on 5 of the 8 factors compared between the two stocks.

How does Zhongchao compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVF) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

In the previous week, Zhongchao had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 2 mentions for Zhongchao and 1 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 1.00 beat Zhongchao's score of -0.28 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company	Overall Sentiment
NewGenIvf Group	Positive
Zhongchao	Neutral

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Zhongchao	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NewGenIvf Group has higher earnings, but lower revenue than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.05	$9.88M	N/A	N/A
Zhongchao	$11.38M	0.09	-$6.31M	N/A	N/A

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 28.6% of Zhongchao shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

NewGenIvf Group has a beta of 0.07, meaning that its share price is 93% less volatile than the broader market. Comparatively, Zhongchao has a beta of -0.03, meaning that its share price is 103% less volatile than the broader market.

Summary

NewGenIvf Group beats Zhongchao on 5 of the 8 factors compared between the two stocks.

Get Zhongchao News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZCMD vs. The Competition

Export

Metric	Zhongchao	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$911K	$9.75B	$7.05B	$13.29B
Dividend Yield	N/A	2.61%	2.53%	16.47%
P/E Ratio	N/A	33.76	275.25	25.94
Price / Sales	0.08	4.80	571.70	85.02
Price / Cash	N/A	119.03	77.41	52.81
Price / Book	0.00	5.05	10.82	6.24
Net Income	-$6.31M	$315.68M	$3.50B	$382.01M
7 Day Performance	-10.45%	-0.99%	-2.58%	-1.66%
1 Month Performance	-7.32%	-3.48%	-8.03%	-5.86%
1 Year Performance	-99.91%	8.62%	2.31%	-1.93%

Zhongchao Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZCMD Zhongchao	0.8172 of 5 stars	$1.59 -6.8%	N/A	-99.9%	$913K	$11.38M	N/A	33	Gap Down
RDGT Ridgetech	0.9063 of 5 stars	$0.80 -0.8%	N/A	-99.5%	$2.93M	$132.16M	N/A	980	News Coverage
IVF INVO Fertility	2.0977 of 5 stars	$0.91 -2.4%	$20.00 +2,095.4%	-97.6%	$2.34M	$7.53M	N/A	46	Positive News
HKPD Hong Kong Pharma Digital Technology	0.5788 of 5 stars	$0.11 +0.3%	N/A	-91.6%	$1.80M	$13.43M	N/A	11	Positive News Gap Down
MNDR Mobile-health Network Solutions	0.7951 of 5 stars	$1.25 -3.8%	N/A	-98.9%	$1.11M	$7.32M	N/A	73	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZCMD) was last updated on 10/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zhongchao (ZCMD) Competitors

ZCMD vs. RDGT, IVF, HKPD, MNDR, and NIVF

How does Zhongchao compare to Ridgetech?

Summary

How does Zhongchao compare to INVO Fertility?

Summary

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Summary

How does Zhongchao compare to Mobile-health Network Solutions?

Summary

How does Zhongchao compare to NewGenIvf Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zhongchao (ZCMD) Competitors

ZCMD vs. RDGT, IVF, HKPD, MNDR, and NIVF

How does Zhongchao compare to Ridgetech?

Which has more volatility & risk, ZCMD or RDGT?

Does the media refer more to ZCMD or RDGT?

Is ZCMD or RDGT more profitable?

Which has preferable earnings and valuation, ZCMD or RDGT?

Do analysts recommend ZCMD or RDGT?

Do insiders & institutionals hold more shares of ZCMD or RDGT?

Summary

How does Zhongchao compare to INVO Fertility?

Do analysts prefer IVF or ZCMD?

Does the media favor IVF or ZCMD?

Which has preferable valuation and earnings, IVF or ZCMD?

Is IVF or ZCMD more profitable?

Do institutionals & insiders have more ownership in IVF or ZCMD?

Which has more volatility & risk, IVF or ZCMD?

Summary

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Is HKPD or ZCMD more profitable?

Do insiders & institutionals hold more shares of HKPD or ZCMD?

Which has stronger earnings & valuation, HKPD or ZCMD?

Which has more risk & volatility, HKPD or ZCMD?

Do analysts prefer HKPD or ZCMD?

Does the media prefer HKPD or ZCMD?

Summary

How does Zhongchao compare to Mobile-health Network Solutions?

Do insiders & institutionals hold more shares of MNDR or ZCMD?

Does the media favor MNDR or ZCMD?

Is MNDR or ZCMD more profitable?

Which has better valuation and earnings, MNDR or ZCMD?

Which has more volatility & risk, MNDR or ZCMD?

Do analysts recommend MNDR or ZCMD?

Summary

How does Zhongchao compare to NewGenIvf Group?

Does the media prefer NIVF or ZCMD?

Is NIVF or ZCMD more profitable?

Do analysts rate NIVF or ZCMD?

Which has higher earnings & valuation, NIVF or ZCMD?

Do insiders and institutionals believe in NIVF or ZCMD?

Which has more risk and volatility, NIVF or ZCMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools